X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA NATCO PHARMA ALEMBIC PHARMA/
NATCO PHARMA
 
P/E (TTM) x 27.8 30.8 90.4% View Chart
P/BV x 6.3 23.3 27.2% View Chart
Dividend Yield % 0.7 0.5 151.1%  

Financials

 ALEMBIC PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
NATCO PHARMA
Mar-14
ALEMBIC PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs792877 90.3%   
Low Rs443424 104.6%   
Sales per share (Unadj.) Rs167.0223.4 74.8%  
Earnings per share (Unadj.) Rs38.231.1 122.8%  
Cash flow per share (Unadj.) Rs42.040.3 104.3%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Dividend yield (eoy) %0.60.8 84.3%  
Book value per share (Unadj.) Rs84.9219.5 38.7%  
Shares outstanding (eoy) m188.5233.07 570.1%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x3.72.9 127.0%   
Avg P/E ratio x16.220.9 77.3%  
P/CF ratio (eoy) x14.716.1 91.1%  
Price / Book Value ratio x7.33.0 245.5%  
Dividend payout %10.516.1 65.1%   
Avg Mkt Cap Rs m116,38321,504 541.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4,2141,128 373.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,4877,389 426.1%  
Other income Rs m55167 33.0%   
Total revenues Rs m31,5427,556 417.4%   
Gross profit Rs m10,0601,793 561.0%  
Depreciation Rs m722304 237.2%   
Interest Rs m37366 10.0%   
Profit before tax Rs m9,3561,290 725.4%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160309 699.8%   
Profit after tax Rs m7,1941,027 700.2%  
Gross profit margin %31.924.3 131.6%  
Effective tax rate %23.123.9 96.5%   
Net profit margin %22.813.9 164.3%  
BALANCE SHEET DATA
Current assets Rs m15,0663,681 409.2%   
Current liabilities Rs m7,6743,123 245.8%   
Net working cap to sales %23.57.6 310.5%  
Current ratio x2.01.2 166.5%  
Inventory Days Days6789 74.8%  
Debtors Days Days4159 69.2%  
Net fixed assets Rs m8,2377,685 107.2%   
Share capital Rs m377331 114.0%   
"Free" reserves Rs m15,4166,670 231.1%   
Net worth Rs m16,0057,259 220.5%   
Long term debt Rs m0955 0.0%   
Total assets Rs m24,59411,957 205.7%  
Interest coverage x255.24.5 5,644.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 207.2%   
Return on assets %29.411.7 252.3%  
Return on equity %44.914.2 317.6%  
Return on capital %58.720.7 283.1%  
Exports to sales %55.739.4 141.6%   
Imports to sales %10.45.7 182.9%   
Exports (fob) Rs m17,5512,908 603.6%   
Imports (cif) Rs m3,283421 779.4%   
Fx inflow Rs m17,8113,445 516.9%   
Fx outflow Rs m5,318703 756.7%   
Net fx Rs m12,4932,743 455.5%   
CASH FLOW
From Operations Rs m9,3041,440 646.0%  
From Investments Rs m-3,105-1,089 285.1%  
From Financial Activity Rs m-1,959-353 555.5%  
Net Cashflow Rs m4,240-1 -284,563.8%  

Share Holding

Indian Promoters % 74.1 52.0 142.4%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 2.9 7.8 37.0%  
FIIs % 9.1 16.6 54.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 26.0 53.5%  
Shareholders   49,328 25,395 194.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Crash in Bitcoin, Correction in MidCap and SmallCap Indices and Top Stocks in Action Today(Pre-Open)

The past year has seen the BSE MidCap and BSE SmallCap indices surging by 43.1% and 57.1% respectively. Taking a two year view these indices have produced mind-boggling return of 75.3% .

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 16, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS